Literature DB >> 35041749

A Causal Link Between Disrupted AKT Signaling and Hyperproliferative Endometrial Diseases.

James K Pru1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35041749      PMCID： PMC8807160          DOI： 10.1210/endocr/bqac006

Source DB:  PubMed          Journal:  Endocrinology        ISSN： 0013-7227            Impact factor:   4.736


× No keyword cloud information.
  8 in total

1.  The histone methyltransferase EZH2 is required for normal uterine development and function in mice†.

Authors:  Manjunatha K Nanjappa; Ana M Mesa; Theresa I Medrano; Wendy N Jefferson; Francesco J DeMayo; Carmen J Williams; John P Lydon; Ellis R Levin; Paul S Cooke
Journal:  Biol Reprod       Date:  2019-08-01       Impact factor: 4.285

2.  Regulation of AKT Signaling in Mouse Uterus.

Authors:  Vijay K Sirohi; Theresa I Medrano; Ana M Mesa; Athilakshmi Kannan; Indrani C Bagchi; Paul S Cooke
Journal:  Endocrinology       Date:  2022-01-01       Impact factor: 4.736

Review 3.  AKT/PKB Signaling: Navigating the Network.

Authors:  Brendan D Manning; Alex Toker
Journal:  Cell       Date:  2017-04-20       Impact factor: 41.582

Review 4.  Influence of AKT on progesterone action in endometrial diseases.

Authors:  Irene I Lee; J Julie Kim
Journal:  Biol Reprod       Date:  2014-08-06       Impact factor: 4.285

5.  Role of nuclear and membrane estrogen signaling pathways in the male and female reproductive tract.

Authors:  Paul S Cooke; Ana M Mesa; Vijay K Sirohi; Ellis R Levin
Journal:  Differentiation       Date:  2020-12-09       Impact factor: 3.880

Review 6.  Membrane-Initiated Estrogen, Androgen, and Progesterone Receptor Signaling in Health and Disease.

Authors:  Franck Mauvais-Jarvis; Carol A Lange; Ellis R Levin
Journal:  Endocr Rev       Date:  2022-07-13       Impact factor: 25.261

Review 7.  PTEN and Gynecological Cancers.

Authors:  Camilla Nero; Francesca Ciccarone; Antonella Pietragalla; Giovanni Scambia
Journal:  Cancers (Basel)       Date:  2019-09-28       Impact factor: 6.639

Review 8.  ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas.

Authors:  Eleftherios P Samartzis; Aurelia Noske; Konstantin J Dedes; Daniel Fink; Patrick Imesch
Journal:  Int J Mol Sci       Date:  2013-09-12       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.